Vuong Trieu, Chairman and CEO at Oncotelic Therapeutics, bought OTLC on Jun 24, 2026
Prices as of Oct 1 · price update delayed · Every feed →
- Traded
- Jun 24, 2026
- Disclosed
- Jun 24, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
OTLC since disclosure
−48.6%
Similar stocks (SPY) since disclosure
+4.2%
S&P 500 (SPY)
Change in closing price from Jun 24, 2026 (the first trading day on or after disclosure) to Oct 1, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▲ BUYVuong Trieu Chairman and CEOOTLC Oncotelic Therapeutics, Inc.$3.4Kdisclosed Jun 24 · filed 1 day after the trade
- ▲ BUYVuong Trieu Chairman and CEOOTLC Oncotelic Therapeutics, Inc.$2.9Kdisclosed Jun 24 · filed 2 days after the trade